dc.contributor.author |
Zeinab R.A. |
dc.contributor.author |
Mroueh M. |
dc.contributor.author |
Diab-Assaf M. |
dc.contributor.author |
Jurjus A. |
dc.contributor.author |
Wex B. |
dc.contributor.author |
Sakr A. |
dc.contributor.author |
Daher C.F. |
dc.contributor.editor |
|
dc.date |
Sep-2011 |
dc.date.accessioned |
2017-09-07T06:59:55Z |
dc.date.available |
2017-09-07T06:59:55Z |
dc.date.issued |
2011 |
dc.identifier |
10.3109/13880209.2011.559250 |
dc.identifier.isbn |
|
dc.identifier.issn |
13880209 |
dc.identifier.uri |
http://hdl.handle.net/10938/11212 |
dc.description.abstract |
Context: Daucus carota L. ssp. carota (Apiacea) is widely distributed throughout the world and has many uses in traditional medicine. Objective: The present study investigates the chemopreventive effects of oil extract of D. carota umbels on 7,12-dimethyl benz(a)anthracene (DMBA)-induced skin cancer in mice. Materials and methods: D. carota oil extract (DCOE) was prepared by extracting the dried umbels with 50:50 acetone:methanol. Skin papilloma were initiated by DMBA and promoted by 12-O-tetradecanoyl phorobol-13-acetate (TPA). The extract was administered to animals via gavage (0.02 mL of 100percent oil), intraperitoneal (0.3 mL of 2percent oil), and topical (0.2 mL of 5, 50, and 100percent oil) routes for 20 weeks. Tumor appearance, incidence, yield, and volume were compared with those of a non-treated control group. Results: Topical 100percent treatment delayed tumor appearance, and inhibited tumor incidence and yield by 40 and 89percent, respectively. Topical 50percent treatment inhibited tumor incidence and yield by 30 and 83percent, respectively, whereas the 5percent treatment inhibited tumor yield by 36percent. Tumor volume was decreased by 99, 91, and 70percent following topical treatments with 100, 50, and 5percent oil, respectively. Intraperitoneal treatment inhibited tumor yield by 43percent, and decreased tumor volume by 85percent, whereas gavage treatment showed minimal effects on both. Intraperitoneal and topical treatment decreased infiltration and hyperplasia with an increase in the level of hyperkeratosis. Conclusion: These findings demonstrate that DCOE has remarkable antitumor activity against DMBA-induced skin cancer compared with non-treated animals paving the ground for further investigations. © 2011 Informa Healthcare USA, Inc. |
dc.format.extent |
|
dc.format.extent |
Pages: (955-961) |
dc.language |
English |
dc.publisher |
LONDON |
dc.relation.ispartof |
Publication Name: Pharmaceutical Biology; Publication Year: 2011; Volume: 49; no. 9; Pages: (955-961); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Chemopreventive effects of wild carrot oil against 7,12-dimethyl benz(a)anthracene-induced squamous cell carcinoma in mice |
dc.type |
Article |
dc.contributor.affiliation |
Zeinab, R.A., Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, P.O. Box 36, Byblos, Lebanon |
dc.contributor.affiliation |
Mroueh, M., School of Pharmacy, Lebanese American University, Byblos, Lebanon |
dc.contributor.affiliation |
Diab-Assaf, M., Faculty of Sciences, Lebanese University, Fanar, Beirut, Lebanon |
dc.contributor.affiliation |
Jurjus, A., School of Medicine, American University of Beirut, Beirut, Lebanon |
dc.contributor.affiliation |
Wex, B., Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, P.O. Box 36, Byblos, Lebanon |
dc.contributor.affiliation |
Sakr, A., Analytical Testing Laboratories, Achrafieh, Beirut, Lebanon |
dc.contributor.affiliation |
Daher, C.F., Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, P.O. Box 36, Byblos, Lebanon |
dc.contributor.authorAddress |
Daher, C.F.; Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, P.O. Box 36, Byblos, Lebanon; email: cdaher@lau.edu.lb |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Anatomy, Cell Biology and Physiological Sciences; |
dc.contributor.authorDepartment |
Anatomy, Cell Biology and Physiological Sciences |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
cdaher@lau.edu.lb |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Abu Zeinab, R |
dc.contributor.authorInitials |
Mroueh, M |
dc.contributor.authorInitials |
Diab-Assaf, M |
dc.contributor.authorInitials |
Jurjus, A |
dc.contributor.authorInitials |
Wex, B |
dc.contributor.authorInitials |
Sakr, A |
dc.contributor.authorInitials |
Daher, CF |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Daher, CF (reprint author), Lebanese Amer Univ, Sch Arts and Sci, Dept Nat Sci, POB 36, Byblos, Lebanon. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
Barnes J, 1998, PHARM J, V260, P344; Committee for the Update of the Guide for the Care and Use of Laboratory Animals National Research Council, 2010, GUIDE CARE USE LAB A; da Silva SL, 2007, EUR J PHARMACOL, V576, P180, DOI 10.1016-j.ejphar.2007.07.065; da Silva Saulo Luis, 2008, Acta Amazonica, V38, P107, DOI 10.1590-S0044-59672008000100012; Diab-Assaf M, 2007, AACR INT C MOL DIAGN, P61; Dwivedi C, 2003, CANCER LETT, V196, P29, DOI 10.1016-S0304-3835(03)00211-8; Farhat GN, 2001, TOXICON, V39, P1601, DOI 10.1016-S0041-0101(01)00143-X; Gali-Muhtasib HU, 2000, PHYTOMEDICINE, V7, P129; HANDA S S, 1986, Fitoterapia, V57, P307; Hanus Lumir O., 2005, Biomedical Papers (Olomouc), V149, P3; Hoffman D, 1991, NEW HOLISTIC HERBAL; Indra AK, 2007, J INVEST DERMATOL, V127, P1250, DOI 10.1038-sj.jid.5700672; Khavari PA, 2006, NAT REV CANCER, V6, P270, DOI 10.1038-nrc1838; Kwon HJ, 2010, CANCER LETT, V290, P96, DOI 10.1016-j.canlet.2009.09.003; Legault J, 2007, J PHARM PHARMACOL, V59, P1643, DOI 10.1211-jpp.59.12.0005; Legault J, 2003, PLANTA MED, V69, P402, DOI 10.1055-s-2003-39695; Lima SRM, 2003, PHYTOTHER RES, V17, P1048, DOI 10.1002-ptr.1295; Mazzio EA, 2009, PHYTOTHER RES, V23, P385, DOI 10.1002-ptr.2636; Mockute D, 2004, J ESSENT OIL RES, V16, P277; Pisano M, 2007, MOL CANCER, V6, DOI 10.1186-1476-4598-6-8; Reed C.F., 1976, INFORM SUMMARI UNPUB; Sporn MB, 2000, CARCINOGENESIS, V21, P525, DOI 10.1093-carcin-21.3.525; Sylvestre M, 2006, J ETHNOPHARMACOL, V103, P99, DOI 10.1016-j.jep.2005.07.011; Konoshima T, 2002, PURE APPL CHEM, V74, P1309, DOI 10.1351-pac200274071309; Thomas KJ, 2001, COMPLEMENT THER MED, V9, P2, DOI 10.1054-ctim.2000.0407; Van Wyk B-E, 2004, MED PLANTS WORLD, P124; Wehbe K, 2009, J COMPLEMENTARY INTE, V6; Owen R W, 2000, Lancet Oncol, V1, P107, DOI 10.1016-S1470-2045(00)00015-2; Zhaorigetu S, 2003, ONCOL REP, V10, P537 |
dc.description.citedCount |
2 |
dc.description.citedTotWOSCount |
1 |
dc.description.citedWOSCount |
1 |
dc.format.extentCount |
7 |
dc.identifier.articleNo |
|
dc.identifier.coden |
PHBIF |
dc.identifier.pubmedID |
21777042 |
dc.identifier.scopusID |
80051517710 |
dc.identifier.url |
|
dc.publisher.address |
TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Pharm. Biol. |
dc.relation.ispartOfIssue |
9 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Pharmaceutical Biology |
dc.relation.ispartofPubTitleAbbr |
Pharm. Biol. |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
49 |
dc.source.ID |
WOS:000293600900010 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
antitumor |
dc.subject.otherAuthKeyword |
Daucus carota L. ssp. carota (Apiacae) |
dc.subject.otherAuthKeyword |
dermal infiltration |
dc.subject.otherAuthKeyword |
hyperkeratosis |
dc.subject.otherAuthKeyword |
skin papilloma |
dc.subject.otherChemCAS |
7,12 dimethylbenz[a]anthracene, 57-97-6 |
dc.subject.otherChemCAS |
acetone, 67-64-1 |
dc.subject.otherChemCAS |
methanol, 67-56-1 |
dc.subject.otherChemCAS |
phorbol 13 acetate 12 myristate, 16561-29-8 |
dc.subject.otherChemCAS |
9,10-Dimethyl-1,2-benzanthracene, 57-97-6 |
dc.subject.otherChemCAS |
Anticarcinogenic Agents |
dc.subject.otherChemCAS |
Carcinogens |
dc.subject.otherChemCAS |
Oils |
dc.subject.otherChemCAS |
Plant Extracts |
dc.subject.otherIndex |
7,12 dimethylbenz[a]anthracene |
dc.subject.otherIndex |
acetone |
dc.subject.otherIndex |
antineoplastic agent |
dc.subject.otherIndex |
daucus carota extract |
dc.subject.otherIndex |
methanol |
dc.subject.otherIndex |
phorbol 13 acetate 12 myristate |
dc.subject.otherIndex |
plant extract |
dc.subject.otherIndex |
unclassified drug |
dc.subject.otherIndex |
animal experiment |
dc.subject.otherIndex |
animal model |
dc.subject.otherIndex |
animal tissue |
dc.subject.otherIndex |
antineoplastic activity |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
cancer inhibition |
dc.subject.otherIndex |
cancer prevention |
dc.subject.otherIndex |
cancer survival |
dc.subject.otherIndex |
carrot |
dc.subject.otherIndex |
chemoprophylaxis |
dc.subject.otherIndex |
controlled study |
dc.subject.otherIndex |
dose response |
dc.subject.otherIndex |
drug efficacy |
dc.subject.otherIndex |
epidermis hyperplasia |
dc.subject.otherIndex |
histopathology |
dc.subject.otherIndex |
hyperkeratosis |
dc.subject.otherIndex |
mouse |
dc.subject.otherIndex |
nonhuman |
dc.subject.otherIndex |
skin cancer |
dc.subject.otherIndex |
skin infiltrate |
dc.subject.otherIndex |
skin papilloma |
dc.subject.otherIndex |
squamous cell carcinoma |
dc.subject.otherIndex |
tumor biopsy |
dc.subject.otherIndex |
tumor volume |
dc.subject.otherIndex |
9,10-Dimethyl-1,2-benzanthracene |
dc.subject.otherIndex |
Animals |
dc.subject.otherIndex |
Anticarcinogenic Agents |
dc.subject.otherIndex |
Carcinogens |
dc.subject.otherIndex |
Carcinoma, Squamous Cell |
dc.subject.otherIndex |
Chemoprevention |
dc.subject.otherIndex |
Daucus carota |
dc.subject.otherIndex |
Flowers |
dc.subject.otherIndex |
Mice |
dc.subject.otherIndex |
Mice, Inbred BALB C |
dc.subject.otherIndex |
Oils |
dc.subject.otherIndex |
Papilloma |
dc.subject.otherIndex |
Phytotherapy |
dc.subject.otherIndex |
Plant Extracts |
dc.subject.otherIndex |
Skin Neoplasms |
dc.subject.otherIndex |
Tumor Burden |
dc.subject.otherIndex |
Animalia |
dc.subject.otherIndex |
Daucus |
dc.subject.otherIndex |
Daucus carota |
dc.subject.otherIndex |
Mus |
dc.subject.otherKeywordPlus |
ANTICANCER ACTIVITY |
dc.subject.otherKeywordPlus |
ALPHA-HUMULENE |
dc.subject.otherKeywordPlus |
IN-VITRO |
dc.subject.otherKeywordPlus |
CANCER |
dc.subject.otherKeywordPlus |
SKIN |
dc.subject.otherKeywordPlus |
PAPILLOMAS |
dc.subject.otherKeywordPlus |
L. |
dc.subject.otherWOS |
Plant Sciences |
dc.subject.otherWOS |
Medical Laboratory Technology |
dc.subject.otherWOS |
Pharmacology and Pharmacy |